Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Molecular Characterization Of De Novo and Therapy-Related MDS/AML With Der(1;7)(q10;p10)

Westman K Maj, MSc, Mette K. Andersen, MD, PhD

Blood (2013) 122 (21): 2585.

https://doi.org/10.1182/blood.V122.21.2585.2585

Published: 2013

Journal Articles

High Early Death Rate with Excellent Survival Beyond Day 30 in Acute Promyelocytic Leukemia Confirmed in Unselected Patients: Results of a Population-Based Registry Study

Jan M. Norgaard, MD, PhD, Lene Sofie Granfeldt Ostgard, MD, Eigil Kjeldsen, MD, Mette S. Holm, MD, PhD, Lars Kjeldsen, MD, PhD, Maria Kallenbach, MD, Marianne T. Severinsen, MD, PhD, Preben Johansen, MD, Lone S. Friis, MD, PhD, Duruta Weber, MD, PhD, Gitte Kerndrup, Birgitte Preiss, MD, Morten K. Jensen, MD, Inge H. Dufva, MD, Susanne Timshel, MD, Mette K. Andersen, MD, PhD, Ove J. Nielsen, MD, PhD

Blood (2012) 120 (21): 3542.

https://doi.org/10.1182/blood.V120.21.3542.3542

Published: 2012

Journal Articles

Different Cytogenetic Patterns in Specified Categories of Secondary AML: Results of a Population-Based Registry Study,

Jan M. Norgaard, MD, PhD, Lene S.G. Oestgaard, MD, Mette K. Andersen, MD, PhD, Maria Kallenbach, MD, Preben Johansen, MD, Knud Bendix, MD, PhD, Gitte Kerndrup, MD, PhD, Birgitte Preiss, MD, Inge Dufva, MD, Susanne Timshel, MD, Joergen Kristensen, MD, PhD, Peter de Nully Brown

Blood (2011) 118 (21): 3586.

https://doi.org/10.1182/blood.V118.21.3586.3586

Published: 2011

Journal Articles

IDH1 and IDH2 Mutations in Therapy-Related Acute Myeloid Leukemia Are Associated with a Normal Karyotype or Der(1;7)(q10;p10) Combined with RUNX1 Mutations,

Maj K. Westman, Morten T. Andersen, Jens Pedersen-Bjergaard, MD, PhD, Mette K. Andersen, MD, PhD

Blood (2011) 118 (21): 3514.

https://doi.org/10.1182/blood.V118.21.3514.3514

Published: 2011

Journal Articles

Epigenetic Silencing of a Novel Candidate Tumor Suppressor “miR” Predicts Poor Prognosis In High-Risk MDS and AML.

Marianne B. Treppendahl, MD, Xiangning Qiu, MD, Christoffer Hother, MD, Mette K. Andersen, MD, PhD, Lars Kjeldsen, MD, PhD, Peter Jones, Professor, Gangning Liang, PhD, Kirsten Gr∅nbæk, MD, PhD

Blood (2010) 116 (21): 3629.

https://doi.org/10.1182/blood.V116.21.3629.3629

Published: 2010

Journal Articles

Relapsed Childhood High Hyperdiploid Acute Lymphoblastic Leukemia: Genome-Wide Screening Reveals the Presence of Preleukemic Ancestral Clones and the Secondary Nature of Microdeletions and RTK-RAS Mutations.

Josef Davidsson, PhD, Kajsa Paulsson, PhD, David Lindgren, PhD, Henrik Lilljebjörn, MS, Tracy Chaplin, MS, Erik Forestier, MD, PhD, Mette K Andersen, MD, PhD, Ann Nordgren, MD, PhD, Richard Rosenquist, MD, PhD, Thoas Fioretos, MD, PhD, Bryan D Young, PhD, Bertil Johansson, MD, PhD

Blood (2009) 114 (22): 2591.

https://doi.org/10.1182/blood.V114.22.2591.2591

Published: 2009

Journal Articles

Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia.

Par Josefsson, MD, Jesper Jurlander, MD, PhD, Christian H. Geisler, MDD.MS, Lone B. Pedersen, Lone Bach, Mette K. Andersen, MD, Henrik Leffers, MS, Anne Mette Buhl, PhD

Blood (2005) 106 (11): 709.

https://doi.org/10.1182/blood.V106.11.709.709

Published: 2005

Journal Articles

Genetic Pathways in t-MDS and t-AML, a Revised Model.

Jens Pedersen-Bjergaard, MD, Ph.D, Debes H. Christiansen, MS, Mette K. Andersen, MD

Blood (2004) 104 (11): 2993.

https://doi.org/10.1182/blood.V104.11.2993.2993

Published: 2004

NARROW

Molecular Characterization Of De Novo and Therapy-Related MDS/AML With Der(1;7)(q10;p10)

High Early Death Rate with Excellent Survival Beyond Day 30 in Acute Promyelocytic Leukemia Confirmed in Unselected Patients: Results of a Population-Based Registry Study

Different Cytogenetic Patterns in Specified Categories of Secondary AML: Results of a Population-Based Registry Study,

IDH1 and IDH2 Mutations in Therapy-Related Acute Myeloid Leukemia Are Associated with a Normal Karyotype or Der(1;7)(q10;p10) Combined with RUNX1 Mutations,

Epigenetic Silencing of a Novel Candidate Tumor Suppressor “miR” Predicts Poor Prognosis In High-Risk MDS and AML.

Relapsed Childhood High Hyperdiploid Acute Lymphoblastic Leukemia: Genome-Wide Screening Reveals the Presence of Preleukemic Ancestral Clones and the Secondary Nature of Microdeletions and RTK-RAS Mutations.

Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia.

Genetic Pathways in t-MDS and t-AML, a Revised Model.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only